BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 9138755)

  • 1. ["De novo" cancer after organ transplantation].
    Launois B; Meunier B; Camus C; Bardaxoglou E; Lakehal M; Caulet-Maugendre S; André P; Ramée MP; Chaperon J; Le Pogamp P; Messner M
    Bull Acad Natl Med; 1996 Nov; 180(8):1869-86; discussion 1886-9. PubMed ID: 9138755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
    Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
    Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo malignances in pediatric organ transplant recipients.
    Penn I
    Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of skin cancer in 5356 patients following organ transplantation.
    Lindelöf B; Sigurgeirsson B; Gäbel H; Stern RS
    Br J Dermatol; 2000 Sep; 143(3):513-9. PubMed ID: 10971322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphoproliferative disease and cancer in the transplant patient].
    Herreros J; Flórez S; Echevarría JR; Fernández AL; Pardo Mindán FJ
    Rev Esp Cardiol; 1995; 48 Suppl 7():129-34. PubMed ID: 8775827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic complications of transplantation.
    Penn I
    Semin Respir Infect; 1993 Sep; 8(3):233-9. PubMed ID: 8016484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of latent Epstein-Barr virus in cutaneous squamoproliferative lesions after solid organ transplantation.
    Huston BM; Maia DM
    Mod Pathol; 1997 Dec; 10(12):1188-93. PubMed ID: 9436962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo tumors in pediatric organ transplant recipients.
    Penn I
    Transplant Proc; 1994 Feb; 26(1):1-2. PubMed ID: 8108892
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancy after solid organ transplantation: an overview.
    Zafar SY; Howell DN; Gockerman JP
    Oncologist; 2008 Jul; 13(7):769-78. PubMed ID: 18614590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for development of de novo neoplasia after liver transplantation.
    Xiol X; Guardiola J; Menendez S; Lama C; Figueras J; Marcoval J; Serrano T; Botargues JM; Mañer M; Rota R
    Liver Transpl; 2001 Nov; 7(11):971-5. PubMed ID: 11699033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.
    Miao Y; Everly JJ; Gross TG; Tevar AD; First MR; Alloway RR; Woodle ES
    Transplantation; 2009 May; 87(9):1347-59. PubMed ID: 19424035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancers after renal transplantation: multicenter experience.
    Harzallah K; Abderrahim E; Chareffedine K; Yeich S; Belhadj R; Skhiri H; Younsi F; Abdallah TB; Abdelletif A; Hachicha J; Hmida J; El May M; Khedr A; Manaa J
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):825-30. PubMed ID: 18711309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
    Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
    Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
    J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancies associated with renal transplantation.
    Penn I
    Urology; 1977 Jul; 10(1 Suppl):57-63. PubMed ID: 329521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo gastrointestinal tumours after renal transplantation: role of CMV and EBV viruses.
    Adani GL; Baccarani U; Lorenzin D; Gropuzzo M; Tulissi P; Montanaro D; Currö G; Sainz M; Risaliti A; Bresadola V; Bresadola F
    Clin Transplant; 2006; 20(4):457-60. PubMed ID: 16842521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.